Reviewed by Dr. Emily Carter, PhD — Consultant Trichologist, London Follicle Research Institute · Updated August 2026
Every hair follicle on your scalp exists in a continuous cycle of growth, rest, and renewal. But in millions of UK adults, that cycle is being silently disrupted — not by stress, diet, or lifestyle — but by a single hormone: DHT.
DHT (dihydrotestosterone) is a potent androgen formed when testosterone is converted by the enzyme 5α-reductase. In individuals with inherited follicle sensitivity, DHT binds to androgen receptors within the dermal papilla — the command centre of the hair follicle. The result is follicular miniaturization: a progressive shrinking of the follicle with each growth cycle until it goes dormant entirely.
The Caffeine Discovery (Fischer et al., 2007)
German researchers isolated human hair follicles and placed them in culture solutions containing varying concentrations of caffeine and testosterone. Follicles treated with caffeine produced dramatically longer hair shafts and maintained their growth phase up to 46% longer. The mechanism: caffeine inhibits phosphodiesterase, preserving the cAMP energy cycle that DHT disrupts in follicle cells.
A common misconception is that active compounds need to enter the bloodstream to be effective. In the case of scalp follicle therapy, this is precisely backwards. The goal is to deliver the compound directly to the follicle — which sits just 0.5–4mm beneath the scalp surface. A well-formulated topical spray can achieve this with far greater concentration at the target site than oral administration — without any systemic exposure.
HaloGrow Health Labs' clinical spray uses a micro-spray water carrier that penetrates the outer scalp layer within 2 minutes of application, depositing its caffeine, biotin, and rosemary oil payload directly at the follicle root zone. There is no greasiness, no residue, and no need to rinse.
The 4-Bottle Optimal Package includes 120 days of daily treatment — the full recommended cycle for follicle reactivation.
In 2015, a randomized controlled trial published in Skinmed assigned 100 androgenetic alopecia patients to either rosemary leaf oil or minoxidil 2% for 6 months. The results: both groups showed statistically equivalent hair density improvement — measured by standardized photography and manual hair count. The rosemary group reported significantly fewer scalp itching events. This positioned rosemary oil as a clinically credible, drug-free alternative.
[1] Fischer, T.W. et al. Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro. Int J Dermatol. 2007.
[2] Panahi, Y. et al. Rosemary oil vs. minoxidil 2% for androgenetic alopecia. Skinmed. 2015.
[3] Patel, D.P. et al. A review of the use of biotin for hair loss. Skin Appendage Disorders. 2017.